Formulation protocol:
1. Yang H, Zhang Y, Chen W, Shi H, Huo L, Li J, Li H, Xie X, She X. Scalable Total Syntheses of (±)-Catellatolactams A and B. Org Lett. 2023 Feb 17;25(6):1003-1007. doi: 10.1021/acs.orglett.3c00132. Epub 2023 Feb 7. PMID: 36748956.
2. Dotsenko VV, Aksenov AV, Sinotsko AE, Varzieva EA, Russkikh AA, Levchenko AG, Aksenov NA, Aksenova IV. The Reactions of N,N'-Diphenyldithiomalondiamide with Arylmethylidene Meldrum's Acids. Int J Mol Sci. 2022 Dec 15;23(24):15997. doi: 10.3390/ijms232415997. PMID: 36555639; PMCID: PMC9785638.
3. Lichitsky BV, Komogortsev AN, Dudinov AA, Krayushkin MM, Khodot EN, Samet AV, Silyanova EA, Konyushkin LD, Karpov AS, Gorses D, Radimerski T, Semenova MN, Kiselyov AS, Semenov VV. Benzimidazolyl-pyrazolo[3,4-b]pyridinones, Selective Inhibitors of MOLT-4 Leukemia Cell Growth and Sea Urchin Embryo Spiculogenesis: Target Quest. ACS Comb Sci. 2019 Dec 9;21(12):805-816. doi: 10.1021/acscombsci.9b00135. Epub 2019 Nov 14. PMID: 31689077.
4. Hussein B, Ikhmais B, Kadirvel M, Magwaza RN, Halbert G, Bryce RA, Stratford IJ, Freeman S. Discovery of potent 4-aminoquinoline hydrazone inhibitors of NRH:quinoneoxidoreductase-2 (NQO2). Eur J Med Chem. 2019 Nov 15;182:111649. doi: 10.1016/j.ejmech.2019.111649. Epub 2019 Aug 27. PMID: 31514018.
In vitro protocol:
1. Yang H, Zhang Y, Chen W, Shi H, Huo L, Li J, Li H, Xie X, She X. Scalable Total Syntheses of (±)-Catellatolactams A and B. Org Lett. 2023 Feb 17;25(6):1003-1007. doi: 10.1021/acs.orglett.3c00132. Epub 2023 Feb 7. PMID: 36748956.
2. Dotsenko VV, Aksenov AV, Sinotsko AE, Varzieva EA, Russkikh AA, Levchenko AG, Aksenov NA, Aksenova IV. The Reactions of N,N'-Diphenyldithiomalondiamide with Arylmethylidene Meldrum's Acids. Int J Mol Sci. 2022 Dec 15;23(24):15997. doi: 10.3390/ijms232415997. PMID: 36555639; PMCID: PMC9785638.
In vivo protocol:
1. Lichitsky BV, Komogortsev AN, Dudinov AA, Krayushkin MM, Khodot EN, Samet AV, Silyanova EA, Konyushkin LD, Karpov AS, Gorses D, Radimerski T, Semenova MN, Kiselyov AS, Semenov VV. Benzimidazolyl-pyrazolo[3,4-b]pyridinones, Selective Inhibitors of MOLT-4 Leukemia Cell Growth and Sea Urchin Embryo Spiculogenesis: Target Quest. ACS Comb Sci. 2019 Dec 9;21(12):805-816. doi: 10.1021/acscombsci.9b00135. Epub 2019 Nov 14. PMID: 31689077.
2. Hussein B, Ikhmais B, Kadirvel M, Magwaza RN, Halbert G, Bryce RA, Stratford IJ, Freeman S. Discovery of potent 4-aminoquinoline hydrazone inhibitors of NRH:quinoneoxidoreductase-2 (NQO2). Eur J Med Chem. 2019 Nov 15;182:111649. doi: 10.1016/j.ejmech.2019.111649. Epub 2019 Aug 27. PMID: 31514018.